Chapter 34: Women's Health Drugs
Pharmacology
A 51-year-old woman will be taking selective estrogen receptor modulators (SERMs) as part
of the treatment for postmenopausal osteoporosis. The nurse reviews potential adverse
effects with this patient, including the possible occurrence of
A. pregnancy.
B. breast cancer.
C. stress fractures.
D. venous thromboembolism. - ANS-ANS: D
\A female patient who lives in New York City is preparing to take a plane trip to Australia.
She has been taking the SERM raloxifene (Evista). The nurse will provide which instructions
to this patient?
A. She should stop taking the drug at least 72 hours before the trip.
B. She must remember to take this drug with a full glass of water each morning.
C. She should increase the calcium supplements that she takes with the drug.
D. No change in interventions is needed. - ANS-ANS: A
\A patient is being treated for primary amenorrhea. The nurse expects which drug to be used
to treat this problem?
A. oxytocin (Pitocin)
B. estradiol transdermal (Estraderm)
C. raloxifene (Evista)
D. medroxyprogesterone (Provera) - ANS-ANS: D
\A patient is receiving oxytocin (Pitocin) to induce labor. During administration of this
medication, the nurse will also implement which action?
A. Giving magnesium sulfate along with the oxytocin
B. Administering the medication in an intravenous bolus
C. Administering the medication with an IV infusion pump
D. Monitoring fetal heart rate and maternal vital signs every 6 hours - ANS-ANS: C
\A patient taking an oral contraceptive should be aware of potential drug interactions with
which medications? Select all that apply.
A. cephalexin (Keflex)
B. guaifenesin (Robitussin)
C. warfarin (Coumadin)
D. isoniazid (INH)
E. ibuprofen (Motrin)
F. theophylline (Uniphyl) - ANS-ANS: A, C, D, F
\A patient wants to try an oral soy product to relieve perimenopausal symptoms. The nurse
will assess the patient's medication history for potential drug interactions, including
Pharmacology
A 51-year-old woman will be taking selective estrogen receptor modulators (SERMs) as part
of the treatment for postmenopausal osteoporosis. The nurse reviews potential adverse
effects with this patient, including the possible occurrence of
A. pregnancy.
B. breast cancer.
C. stress fractures.
D. venous thromboembolism. - ANS-ANS: D
\A female patient who lives in New York City is preparing to take a plane trip to Australia.
She has been taking the SERM raloxifene (Evista). The nurse will provide which instructions
to this patient?
A. She should stop taking the drug at least 72 hours before the trip.
B. She must remember to take this drug with a full glass of water each morning.
C. She should increase the calcium supplements that she takes with the drug.
D. No change in interventions is needed. - ANS-ANS: A
\A patient is being treated for primary amenorrhea. The nurse expects which drug to be used
to treat this problem?
A. oxytocin (Pitocin)
B. estradiol transdermal (Estraderm)
C. raloxifene (Evista)
D. medroxyprogesterone (Provera) - ANS-ANS: D
\A patient is receiving oxytocin (Pitocin) to induce labor. During administration of this
medication, the nurse will also implement which action?
A. Giving magnesium sulfate along with the oxytocin
B. Administering the medication in an intravenous bolus
C. Administering the medication with an IV infusion pump
D. Monitoring fetal heart rate and maternal vital signs every 6 hours - ANS-ANS: C
\A patient taking an oral contraceptive should be aware of potential drug interactions with
which medications? Select all that apply.
A. cephalexin (Keflex)
B. guaifenesin (Robitussin)
C. warfarin (Coumadin)
D. isoniazid (INH)
E. ibuprofen (Motrin)
F. theophylline (Uniphyl) - ANS-ANS: A, C, D, F
\A patient wants to try an oral soy product to relieve perimenopausal symptoms. The nurse
will assess the patient's medication history for potential drug interactions, including
